GB2535562B - Hydrogel compositions and their use in the treatment of symptoms induced by hypertrophic scars - Google Patents

Hydrogel compositions and their use in the treatment of symptoms induced by hypertrophic scars

Info

Publication number
GB2535562B
GB2535562B GB1515296.0A GB201515296A GB2535562B GB 2535562 B GB2535562 B GB 2535562B GB 201515296 A GB201515296 A GB 201515296A GB 2535562 B GB2535562 B GB 2535562B
Authority
GB
United Kingdom
Prior art keywords
treatment
hypertrophic scars
hydrogel compositions
symptoms induced
symptoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB1515296.0A
Other versions
GB2535562B8 (en
GB2535562A (en
GB2535562A8 (en
GB201515296D0 (en
Inventor
Wu Jun
Luo Gaoxing
Yiunam Lau Johnson
Fok Manson
Wong Chun-Ho
Flury Meinrad
Tak Kwong Lee Benhamin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chongqing Mj Medical Devices Co Ltd
Original Assignee
Chongqing Mj Medical Devices Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chongqing Mj Medical Devices Co Ltd filed Critical Chongqing Mj Medical Devices Co Ltd
Publication of GB201515296D0 publication Critical patent/GB201515296D0/en
Publication of GB2535562A publication Critical patent/GB2535562A/en
Publication of GB2535562B publication Critical patent/GB2535562B/en
Application granted granted Critical
Publication of GB2535562B8 publication Critical patent/GB2535562B8/en
Publication of GB2535562A8 publication Critical patent/GB2535562A8/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Materials For Medical Uses (AREA)
GB1515296.0A 2014-09-30 2015-08-28 Hydrogel compositions and their use in the treatment of symptoms induced by hypertrophic scars Expired - Fee Related GB2535562B8 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IB2014088001 2014-09-30

Publications (5)

Publication Number Publication Date
GB201515296D0 GB201515296D0 (en) 2015-10-14
GB2535562A GB2535562A (en) 2016-08-24
GB2535562B true GB2535562B (en) 2017-03-29
GB2535562B8 GB2535562B8 (en) 2017-07-19
GB2535562A8 GB2535562A8 (en) 2017-07-19

Family

ID=54326467

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1515296.0A Expired - Fee Related GB2535562B8 (en) 2014-09-30 2015-08-28 Hydrogel compositions and their use in the treatment of symptoms induced by hypertrophic scars

Country Status (1)

Country Link
GB (1) GB2535562B8 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114748413B (en) * 2022-03-14 2023-11-28 云南贝泰妮生物科技集团股份有限公司 Hydrogel composition for inhibiting scar formation and preparation method and application thereof
WO2024026572A1 (en) * 2022-08-05 2024-02-08 Denis Simioni Skin dough composition

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103340843A (en) * 2013-07-11 2013-10-09 中国人民解放军第三军医大学第一附属医院 Macromolecular compound latex scar paste applied to inhibiting discomforts such as pruritus
EP2765160A1 (en) * 2011-10-04 2014-08-13 Genic Co., Ltd. Hydrogel composition for a mask base and method for manufacturing a hydrogel using same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2765160A1 (en) * 2011-10-04 2014-08-13 Genic Co., Ltd. Hydrogel composition for a mask base and method for manufacturing a hydrogel using same
CN103340843A (en) * 2013-07-11 2013-10-09 中国人民解放军第三军医大学第一附属医院 Macromolecular compound latex scar paste applied to inhibiting discomforts such as pruritus

Also Published As

Publication number Publication date
GB2535562B8 (en) 2017-07-19
GB2535562A (en) 2016-08-24
GB2535562A8 (en) 2017-07-19
GB201515296D0 (en) 2015-10-14

Similar Documents

Publication Publication Date Title
IL283086A (en) Use of cannabidiol in the treatment of tuberous sclerosis complex
IL281793A (en) Use of cannabinoids in the treatment of epilepsy
GB2548873B (en) Use of Cannabidiol in the Treatment of SturgeWeber Syndrome
PL3157512T3 (en) Use of cannabidiol in the treatment of epilepsy
EP3137116A4 (en) Dendrimer compositions and their use in treatment of diseases of the eye
GB201411496D0 (en) Use of 7-Oh-Cannabidiol (7-Oh-CBD) and/or 7-Oh-Cannabidvarin (7-Oh-CBDV) in the treatment of epilepsy
IL276733A (en) Use of eribulin in the treatment of cancer
IL251351B (en) Compositions for use in the treatment and prophylaxis of surgical site infections
IL251904A0 (en) Apilimod for use in the treatment of melanoma
PL3160464T3 (en) 6-hydroxybuspirone for use in the treatment of movement disorders
IL246855A0 (en) Agents for use in the treatment of retinal inflammation
HK1225994A1 (en) Compositions for use in the treatment of allergic conditions
PL3197556T3 (en) Composition for the prevention and/or treatment of allergy symptoms
HK1217913A1 (en) Use of adelmidrol in the treatment of epithelial dysfunctions
GB2535562B8 (en) Hydrogel compositions and their use in the treatment of symptoms induced by hypertrophic scars
PL3229780T3 (en) Ophthalmic compositions for use in the treatment of the dry eye syndrome
GB201513543D0 (en) Compositions for use in the treatment of diabetes
ZA201408464B (en) Composition for the use in treatment of asthma
TH182881B (en) Composition for use in the treatment of anaphylaxis
ZA201404780B (en) Composition for use in treatment of diabetes
ZA201403006B (en) Composition for use in treatment of cancer

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20190828